BALA CYNWYD, Pa., Oct. 31, 2022 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following research. If you own stock and would like to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. You will not incur any costs or financial obligations.
Altra Industrial Motion Corp. (Nasdaq-AIMC)
Under the terms of the Agreement, Altra will be acquired by Regal Rexnord Corporation (“Regal Rexnord”). Regal Rexnord will acquire each outstanding share of Altra for $62.00 per share in a cash transaction valued at approximately $5.0 billion on an enterprise value basis. The investigation concerns whether Altra’s board of directors breached its fiduciary duties to shareholders by failing to conduct a fair trial and whether Regal Rexnord is underpaying the company.
For more information, see https://www.brodskysmith.com/cases/altra-industrial-motion-corp-nasdaq-aimc/.
UserTesting, Inc. (NYSE – USER)
Under the terms of the Agreement, UserTesting will be owned by Thoma Bravo and Sunstone Partners (“Purchaser”). Purchasers will purchase each outstanding share of UserTesting for $7.50 per share in a cash transaction valued at approximately $1.3 billion. The investigation concerns whether the UserTesting Board breached its fiduciary duties to shareholders by failing to conduct a fair trial and whether buyers are underpaying the company. For example, the transaction consideration is below the 52-week high of $15.98 for the company’s shares.
For more information, see https://www.brodskysmith.com/cases/usertesting-inc-nyse-user/.
AVEO Pharmaceuticals, Inc. (Nasdaq AVEO)
Under the terms of the agreement, AVEO will be acquired by LG Chem, Ltd. (“LG Chem”). LG Chem will pay $15.00 per share in cash for all outstanding shares of AVEO. The deal has an implied equity value of $566 million. The investigation concerns whether the AVEO board will exercise its fiduciary…
